{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:05:48Z","timestamp":1792465548088,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hjc.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T06:30:39Z","timestamp":1788503439000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular-kidney-metabolic syndrome: definition, staging, diagnosis and therapeutic management. An expert consensus statement of the Committee of cardiovascular-kidney-metabolic syndrome of the Hellenic Society of Cardiology"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-684X","authenticated-orcid":false,"given":"Dimitrios","family":"Patoulias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8328-5942","authenticated-orcid":false,"given":"Efstratios","family":"Karagiannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Maragkoudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1774-0832","authenticated-orcid":false,"given":"Ioannis","family":"Alexanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7158-4950","authenticated-orcid":false,"given":"Nikolaos","family":"Fragakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2026.08.007_bib1","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2026.08.007_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2026.08.007_bib3","first-page":"2167","article-title":"Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023","volume":"86","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib4","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"22S","key":"10.1016\/j.hjc.2026.08.007_bib5","doi-asserted-by":"crossref","first-page":"e1889","DOI":"10.1016\/j.jacc.2026.03.056","article-title":"2026 AHA\/ACC\/ADA\/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"87","author":"Ndumele","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib6","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","article-title":"Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement","volume":"46","author":"Romeo","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib7","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.hjc.2026.08.007_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/biom15020213","article-title":"From Cardiovascular-Kidney-Metabolic Syndrome to Cardiovascular-Renal-Hepatic-Metabolic Syndrome: Proposing an Expanded Framework","volume":"15","author":"Theodorakis","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.hjc.2026.08.007_bib9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ecl.2008.06.007","article-title":"Obesity and free fatty acids","volume":"37","author":"Boden","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.hjc.2026.08.007_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.hjc.2026.08.007_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/415339a","article-title":"Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase","volume":"415","author":"Minokoshi","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.hjc.2026.08.007_bib12","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: A narrative review with a focus on Japan","volume":"24","author":"Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.hjc.2026.08.007_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hjc.2026.08.007_bib14","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinte.164.16.1737","article-title":"Diabetes mellitus, the renin-angiotensin-aldosterone system, and the heart","volume":"164","author":"Lim","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.atherosclerosis.2015.06.006","article-title":"Insulin resistance and acute glucose changes determine arterial elastic properties and coronary flow reserve in dysglycaemic and first-degree relatives of diabetic patients","volume":"241","author":"Ikonomidis","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hjc.2026.08.007_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijcard.2017.01.056","article-title":"Early detection of left ventricular dysfunction in first-degree relatives of diabetic patients by myocardial deformation imaging: the role of endothelial glycocalyx damage","volume":"233","author":"Ikonomidis","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib17","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.hjc.2026.08.007_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced glycation end products and diabetic complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1016\/j.hjc.2026.08.007_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S2213-8587(23)00165-1","article-title":"Precision medicine for cardiometabolic disease: a framework for clinical translation","volume":"11","author":"Franks","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.hjc.2026.08.007_bib20","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2213-8587(23)00361-3","article-title":"Air pollution exposure and cardiometabolic risk","volume":"12","author":"Rajagopalan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.hjc.2026.08.007_bib21","article-title":"Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study","volume":"35","author":"Cordova","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hjc.2026.08.007_bib22","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1001\/jama.2024.6892","article-title":"Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020","volume":"331","author":"Aggarwal","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.hjc.2026.08.007_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2025.101369","article-title":"Cardiovascular-kidney-metabolic syndrome stages and increased risk of all-cause and cause-specific mortality in UK Biobank","volume":"25","author":"Xu","year":"2026","journal-title":"Am J Prev Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.nefroe.2024.11.011","article-title":"Cardiovascular-kidney-metabolic syndrome definition and its role in the prevention, risk staging, and treatment. An opportunity for the Nephrology","volume":"44","author":"Cases","year":"2024","journal-title":"Nefrologia (Engl Ed)"},{"key":"10.1016\/j.hjc.2026.08.007_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004629","article-title":"Cardiovascular-kidney-metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study","volume":"22","author":"Tsai","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101843","article-title":"Prevalence and Mortality Association of Different Stages of Cardiovascular-Kidney-Metabolic Syndrome","volume":"4","author":"Chen","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.hjc.2026.08.007_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/21501319251379732","article-title":"Cardio-renal-metabolic (CRM): Call for action for European Guidelines for Primary Care Physicians","volume":"16","author":"Saemann","year":"2025","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.hjc.2026.08.007_bib28","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney International"},{"key":"10.1016\/j.hjc.2026.08.007_bib29","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.hjc.2024.05.018","article-title":"Establishing a cardiometabolic outpatient department in Greece: a roadmap for multidisciplinary care","volume":"80","author":"Michas","year":"2024","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40256-025-00761-w","article-title":"Definition, Classification, Diagnosis, and Management of an Emerging Threat: Cardio-Renal-Metabolic Syndrome","volume":"26","author":"Koufakis","year":"2026","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.hjc.2026.08.007_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102509","article-title":"Long-term impact of mediterranean diet on cardiovascular disease prevention: A systematic review and meta-analysis of randomized controlled trials","volume":"49","author":"Sebastian","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib32","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"European Heart Journal"},{"key":"10.1016\/j.hjc.2026.08.007_bib33","doi-asserted-by":"crossref","first-page":"4359","DOI":"10.1093\/eurheartj\/ehaf190","article-title":"2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"46","author":"Mach","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib34","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hjc.2026.08.007_bib35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s12933-021-01430-3","article-title":"SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"10166","key":"10.1016\/j.hjc.2026.08.007_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2026.08.007_bib37","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1111\/dom.13847","article-title":"GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials","volume":"21","author":"Giugliano","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.hjc.2026.08.007_bib38","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.hjc.2026.08.007_bib39","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"20","key":"10.1016\/j.hjc.2026.08.007_bib40","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/j.jacc.2025.08.027","article-title":"Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients","volume":"86","author":"Galli","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015716","volume":"9","author":"Ikonomidis","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2026.08.007_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.039129","article-title":"Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on neurohumoral and mitochondrial activation in patients with diabetes","volume":"14","author":"Ikonomidis","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2026.08.007_bib43","doi-asserted-by":"crossref","first-page":"H610","DOI":"10.1152\/ajpheart.00996.2025","article-title":"GLP-1 receptor agonists, SGLT-2 inhibitors, and their combination: effects on carotid atherosclerosis regression, oxidative stress, and amyloid-\u03b21-40 in diabetes","volume":"330","author":"Ikonomidis","year":"2026","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.hjc.2026.08.007_bib44","article-title":"Myocardial deformation links combined liraglutide-empagliflozin therapy with improved cardiovascular and economic outcoes in type 2 diabetes: a 6-year study","volume":"4","author":"4Thymis","year":"2026","journal-title":"Eur Heart J Imaging Methods Pract"},{"key":"10.1016\/j.hjc.2026.08.007_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2024.108800","article-title":"Achievement of normoglycemia with tirzepatide in type 2 diabetes mellitus: A step closer to drug-induced diabetes remission?","volume":"38","author":"Popovic","year":"2024","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.hjc.2026.08.007_bib46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib47","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.025079","article-title":"Generalizability of FIGARO-DKD and FIDELIO-DKD Trial Criteria to the US Population Eligible for Finerenone","volume":"11","author":"Chiu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2026.08.007_bib48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/ndt\/gfac194","article-title":"Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the KNOW-CKD","volume":"38","author":"Jung","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.hjc.2026.08.007_bib49","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1681\/ASN.2014020173","article-title":"Subclinical atherosclerosis measures for cardiovascular prediction in CKD","volume":"26","author":"Matsushita","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.hjc.2026.08.007_bib50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","article-title":"Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the Multi-Ethnic Study of Atherosclerosis","volume":"2","author":"Malik","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib51","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s40265-024-02105-5","article-title":"2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)","volume":"84","author":"Banach","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.hjc.2026.08.007_bib52","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib53","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib54","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib55","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/HJH.0b013e3280115bfb","article-title":"Weight loss after bariatric surgery improves aortic elastic properties and left ventricular function in individuals with morbid obesity: a 3-year follow-up study","volume":"25","author":"Ikonomidis","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.hjc.2026.08.007_bib56","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib57","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib58","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib59","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib60","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"McDonagh","year":"2023","journal-title":"European Heart Journal"},{"key":"10.1016\/j.hjc.2026.08.007_bib61","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.hjc.2026.08.007_bib62","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1002\/ejhf.70082","article-title":"Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document","volume":"27","author":"Monzo","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.hjc.2026.08.007_bib63","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/S0140-6736(25)00509-4","article-title":"Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial","volume":"405","author":"Bonaca","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2026.08.007_bib64","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's Essential 8: Updating and Enhancing the American Heart Association's Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2026.08.007_bib65","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/eurjpc\/zwae280","article-title":"Life's Essential 8 and the risk of cardiovascular disease: a systematic review and meta-analysis","volume":"32","author":"Sebastian","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf247","article-title":"Life's Essential 8 and progression of cardiometabolic multimorbidity trajectory: a prospective study of UK Biobank","author":"Huang","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2025.101788","article-title":"Lifestyle Interventions in Cardiovascular-Kidney-Metabolic Syndrome JACC: Advances Expert Panel","volume":"4","author":"Shahid","year":"2025","journal-title":"JACC Adv"},{"key":"10.1016\/j.hjc.2026.08.007_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1186\/s12933-025-03029-4","article-title":"Exercise in CKM syndrome progression: a stage-specific approach to cardiovscular, metabolic, and renal health","volume":"24","author":"6Papadakis","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.hjc.2026.08.007_bib69","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.eprac.2025.07.017","article-title":"American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity\/Adiposity-Based Chronic Disease - 2025 Update","volume":"31","author":"Nadolsky","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.hjc.2026.08.007_bib70","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(22)00122-2","article-title":"Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial","volume":"399","author":"Delgado-Lista","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.hjc.2026.08.007_bib71","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2026.08.007_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hjc.2024.04.004","article-title":"Dietary habits among 177,091 Greek schoolchildren by age, sex, weight status, region, and living area. A cross-sectional study","volume":"85","author":"Tambalis","year":"2025","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2026.08.007_bib73","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.3390\/ijms25052475","article-title":"The effect of a ketogenic diet versus Mediterranean diet on clinical and biochemical markers of inflammation in patients with obesity and psoriatic arthritis: a randomized crossover trial","volume":"25","author":"Lambadiari","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.hjc.2026.08.007_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.pcd.2023.10.007","article-title":"Cardiometabolic risk profile of young and old adults with diabetes: Pooled, cross-sectional analysis of 42 national health surveys","volume":"17","author":"Carrillo-Larco","year":"2023","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.hjc.2026.08.007_bib75","doi-asserted-by":"crossref","unstructured":"Zhao C, Ma T, He L, Song C, Cheng X, Bai Y. The additive association of cardiometabolic diseases with incident heart failure: a prospective cohort study. Hellenic J Cardiol. 2025 Jun 18:S1109-9666(25)00147-2. doi: 10.1016\/j.hjc.2025.06.005. Epub ahead of print.","DOI":"10.1016\/j.hjc.2025.06.005"},{"key":"10.1016\/j.hjc.2026.08.007_bib76","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000001221","article-title":"Implementation of Obesity Science Into Clinical Practice: A Scientific Statement From the American Heart Association","volume":"150","author":"Laddu","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2026.08.007_bib77","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12020-022-03030-x","article-title":"Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better?","volume":"76","author":"Moltrer","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/j.hjc.2026.08.007_bib78","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029083","article-title":"Subclinical Cardiovascular Disease in US Adults With and Without Diabetes","volume":"12","author":"Fang","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2026.08.007_bib79","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hjc.2026.08.007_bib80","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib81","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/heartjnl-2015-308796","article-title":"The clinical impact of contemporary stress echocardiography in morbid obesity for the assessment of coronary artery disease","volume":"102","author":"Shah","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.hjc.2026.08.007_bib82","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/ERP-16-0010","article-title":"Stress echocardiography in patients with morbid obesity","volume":"3","author":"Shah","year":"2016","journal-title":"Echo Res Pract"},{"key":"10.1016\/j.hjc.2026.08.007_bib83","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/echo.12481","article-title":"Feasibility and prognostic value of stress echocardiography in obese, morbidly obese, and super obese patients referred for bariatric surgery","volume":"31","author":"Supariwala","year":"2014","journal-title":"Echocardiography"},{"key":"10.1016\/j.hjc.2026.08.007_bib84","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1093\/eurheartj\/ehab775","article-title":"Coronary flow reserve and cardiovascular outcomes: a systematic review and meta-analysis","volume":"43","author":"Kelshiker","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib85","doi-asserted-by":"crossref","unstructured":"Park S, Park EJ, Lee SH, et al. Impact of renal function on treatment strategies and clinical outcomes in acute myocardial infarction patients with multivessel disease. Hellenic J Cardiol. 2025 Feb 17:S1109-9666(25)00040-5. doi: 10.1016\/j.hjc.2025.02.001. Epub ahead of print.","DOI":"10.1016\/j.hjc.2025.02.001"},{"key":"10.1016\/j.hjc.2026.08.007_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034996","article-title":"Social Risk Profile and Cardiovascular-Kidney-Metabolic Syndrome in US Adults","volume":"13","author":"Li","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hjc.2026.08.007_bib87","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.123.322055","article-title":"Gut Microbiota and Microbial Metabolism in Early Risk of Cardiometabolic Disease","volume":"132","author":"Gabriel","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.hjc.2026.08.007_bib88","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehac648","article-title":"Polygenic risk scores for the prediction of cardiometabolic disease","volume":"44","author":"O'Sullivan","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2026.08.007_bib89","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.2337\/dc26-S002","article-title":"Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026","volume":"49","author":"Bajaj","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.hjc.2026.08.007_bib90","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1161\/CIR.0000000000001396","volume":"152","author":"Jones","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2026.08.007_bib91","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966626001399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966626001399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:46:41Z","timestamp":1789764401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966626001399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":91,"alternative-id":["S1109966626001399"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2026.08.007","relation":{},"ISSN":["1109-9666"],"issn-type":[{"value":"1109-9666","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular-kidney-metabolic syndrome: definition, staging, diagnosis and therapeutic management. An expert consensus statement of the Committee of cardiovascular-kidney-metabolic syndrome of the Hellenic Society of Cardiology","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}